Cas:168466-85-1 1-Benzyl-3-piperidinamine manufacturer & supplier

Chemical Name:1-Benzyl-3-piperidinamine

CAS.NO:168466-85-1

Synonyms:(S)-3-Amino-1-benzylpiperidine;(3S)-1-Benzylpiperidin-3-amine;MFCD03093375;3-Piperidinamine, 1-(phenylmethyl)-, (3S)-;1-Benzyl-3-piperidinamine;3-Piperidinamine, 1-(phenylmethyl)-;(S)-1-Benzyl-3-aminopiperidine;(3S)-1-Benzyl-3-piperidinamine;1-benzylpiperidin-3-amine

Molecular Formula:C₁₂H₁₈N₂

Molecular Weight:190.285

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:281.2±33.0 °C at 760 mmHg

Density:1.0±0.1 g/cm3

Index of Refraction:1.561

PSA:29.26000

Exact Mass:190.147003

LogP:1.46

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (S)-3-Amino-1-benzylpiperidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-benzylpiperidin-3-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Piperidinamine, 1-(phenylmethyl)- Use and application,3-Piperidinamine, 1-(phenylmethyl)-, (3S)- technical grade,usp/ep/jp grade.

Related News: ��With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.�� 1-Benzyl-3-piperidinamine manufacturer The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development. 1-Benzyl-3-piperidinamine supplier ��With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.�� 1-Benzyl-3-piperidinamine vendor At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. 1-Benzyl-3-piperidinamine factory The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development.